SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: M.LUTH who wrote (385)8/15/1997 4:18:00 PM
From: luis a. garcia   of 1115
 
Mike realistically speaking if they comercialize in 3 or 4 months and start production in the US, Europe and Asia ... I think 10 bucks is a given... and depending on distribution and market share and the cost of phase III for Kaposi and LMI etc who knows... over the counter is a
great posssibility etc... but 10 to 15 bucks is not unreasonable.. next year.... again lots of R&D going on and... the only thing we know for certain is they are applying for drug status in US and Europe and Asia for LIDAKOL which by the way you would be happy to know will be used for both oral and genital herpes by most physicians... Kaposi too.

luis
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext